


Ask a doctor about a prescription for IRBESARTAN/HYDROCHLOROTHIAZIDE PENSA 300 mg/12.5 mg TABLETS
Package Leaflet: Information for the User
Irbesartan/Hydrochlorothiazide Pensa 300 mg/12.5 mg film-coated tabletEFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Irbesartan/Hydrochlorothiazide Pensa is a combination of two active substances, irbesartan and hydrochlorothiazide.
Irbesartan belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels, causing them to constrict. This results in an increase in blood pressure. Irbesartan prevents angiotensin-II from binding to these receptors, relaxing the blood vessels and reducing blood pressure.
Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics, which increase the amount of urine excreted, reducing blood pressure.
The two active substances in irbesartan/hydrochlorothiazide work together to achieve a greater reduction in blood pressure than either substance alone.
Irbesartan/Hydrochlorothiazide is used to treat high blood pressure when treatment with irbesartan or hydrochlorothiazide alone does not provide adequate control of blood pressure.
Do not take Irbesartan/Hydrochlorothiazide Pensa
Warnings and precautions
Consult your doctor or pharmacist before starting to take Irbesartan/Hydrochlorothiazide Pensa and in any of the following cases:
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Irbesartan/Hydrochlorothiazide Pensa. Your doctor will decide whether to continue treatment. Do not stop taking Irbesartan/Hydrochlorothiazide Pensa on your own.
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the heading “Do not take Irbesartan/Hydrochlorothiazide Pensa”
If you are pregnant, think you may be pregnant, or are planning to become pregnant, inform your doctor. Irbesartan/hydrochlorothiazide is not recommended during the first trimester of pregnancy (first 3 months) and must not be taken after the third month of pregnancy as it may cause serious harm to your baby (see section Pregnancy)
You must also inform your doctor:
Hydrochlorothiazide, which is contained in this medicine, may cause positive results in doping tests.
Children and adolescents
Irbesartan/Hydrochlorothiazide Pensa should not be given to children and adolescents (under 18 years of age).
Other medicines and Irbesartan/Hydrochlorothiazide Pensa
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
Diuretics, such as hydrochlorothiazide contained in Irbesartan/Hydrochlorothiazide Pensa, may interact with other medicines. You should not take preparations containing lithium with Irbesartan/Hydrochlorothiazide Pensa without your doctor's supervision.
Your doctor may need to adjust your dose and/or take other precautions.
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Irbesartan/Hydrochlorothiazide Pensa” and “Warnings and precautions”).
You may need to haveblood testsif you take:
It is also important to inform your doctor if you are taking other medicines to lower your blood pressure, steroids, cancer treatments, painkillers, medicines for arthritis, or cholestyramine or colestipol resins to lower blood cholesterol levels.
Taking Irbesartan/Hydrochlorothiazide Pensa with food, drinks, and alcohol
Irbesartan/Hydrochlorothiazide can be taken with or without food.
Due to the hydrochlorothiazide contained in Irbesartan/Hydrochlorothiazide Pensa, if you drink alcohol while being treated with this medicine, you may experience increased dizziness when standing up, especially when getting up from a sitting position.
Pregnancy and breastfeeding
Pregnancy
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medicine. Your doctor will normally advise you to stop taking irbesartan/hydrochlorothiazide before you become pregnant or as soon as you find out you are pregnant and will recommend that you take a different blood pressure-lowering medicine instead. Irbesartan/hydrochlorothiazide is not recommended during the first trimester of pregnancy and must not be taken after the third month of pregnancy as it may cause serious harm to your baby.
Breastfeeding
Tell your doctor if you are about to start or are already breastfeeding, as irbesartan/hydrochlorothiazide is not recommended for use during breastfeeding. Your doctor may decide to prescribe a treatment that is more suitable for you, especially if you are breastfeeding a newborn or premature baby.
Driving and using machines
Irbesartan/hydrochlorothiazide is unlikely to affect your ability to drive or use machines. However, during treatment of high blood pressure, dizziness or fatigue may occasionally occur. If you experience these symptoms, talk to your doctor before driving or using machines.
Irbesartan/Hydrochlorothiazide Pensa contains castor oil, lactose, and sodium
This medicine may cause stomach upset and diarrhea because it contains hydrogenated castor oil.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
Dose
The recommended dose of irbesartan/hydrochlorothiazide is one tablet per day. In general, your doctor will prescribe irbesartan/hydrochlorothiazide when previous treatments have not sufficiently reduced your blood pressure. Your doctor will tell you how to switch from previous treatments to irbesartan/hydrochlorothiazide Pensa.
Method of administration
Irbesartan/Hydrochlorothiazide is taken orally. The tablets should be swallowed with a sufficient amount of liquid (e.g., a glass of water). You can take irbesartan/hydrochlorothiazide with or without food. Try to take your daily dose at the same time each day. It is important that you continue to take irbesartan/hydrochlorothiazide until your doctor tells you to stop.
The maximum blood pressure-lowering effect should be achieved within 6-8 weeks after starting treatment.
Use in children and adolescents
Children should not take Irbesartan/Hydrochlorothiazide Pensa.
Irbesartan/Hydrochlorothiazide should not be given to children under 18 years of age. If a child swallows some tablets, contact your doctor immediately.
If you take more Irbesartan/Hydrochlorothiazide Pensa than you should
If you accidentally take too many tablets, contact your doctor immediately.
In case of overdose or accidental ingestion, go to a Medical Center or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount used. It is recommended to bring the packaging and the leaflet of the medicine.
If you forget to take Irbesartan/Hydrochlorothiazide Pensa
If you accidentally miss a dose, simply take your normal dose when it is due. Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Some of these effects can be serious and may require medical attention.
Rarely, cases of skin allergic reactions (skin rash, hives) have been reported in patients treated with irbesartan, as well as localized inflammation in the face, lips, and/or tongue. If you have any of the above symptoms or experience shortness of breath, stop taking irbesartan/hydrochlorothiazide and contact your doctor immediately.
The frequency of the adverse effects listed below is defined using the following convention:
Frequent: may affect up to 1 in 10 people
Infrequent: may affect up to 1 in 100 people
Very rare: may affect up to 1 in 10,000 people. The adverse effects reported in clinical studies for patients treated with irbesartan/hydrochlorothiazide were:
Frequent Adverse Effects(may affect up to 1 in 10 people)
If any of these adverse effects cause you problems, consult your doctor.
Infrequent Adverse Effects(may affect up to 1 in 100 people)
If any of these adverse effects cause you problems, consult your doctor.
Adverse Effects Since the Marketing of Irbesartan/Hydrochlorothiazide Pensa
Since the marketing of irbesartan/hydrochlorothiazide, some adverse effects have been reported. The adverse effects observed with unknown frequency are: headache, ringing in the ears, cough, altered taste, indigestion, joint and muscle pain, liver function disorders, and kidney failure, high levels of potassium in your blood, and allergic reactions such as skin rash, hives, swelling of the face, lips, mouth, tongue, or throat.
Additionally, rare cases of jaundice (yellowing of the skin and/or whites of the eyes) have been observed.
As with all combinations of two active ingredients, the adverse effects associated with each component cannot be excluded.
Adverse Effects Associated Only with Irbesartan
In addition to the adverse effects described above, chest pain, severe allergic reactions (anaphylactic shock), and decreased red blood cell count (anemia - symptoms may include fatigue, headaches, difficulty breathing when exercising, dizziness, and paleness) and decreased platelet count (a blood cell essential for blood clotting) and low blood sugar levels have also been observed.
Rare adverse effects (may affect at least 1 in 1,000 people): intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Adverse Effects Associated with Hydrochlorothiazide in Monotherapy
Lack of appetite, stomach irritation; stomach cramps; constipation; jaundice (yellowing of the skin and/or whites of the eyes); pancreatitis characterized by severe upper stomach pain, often with nausea and vomiting; sleep disorders; depression; blurred vision; lack of white blood cells, which can lead to frequent infections, fever; decreased platelet count (blood cells essential for blood clotting), decreased red blood cell count (anemia) characterized by fatigue, headaches, shortness of breath when exercising, dizziness, and paleness; kidney disease; pulmonary disorders including pneumonia or fluid accumulation in the lungs; increased skin sensitivity to the sun; inflammation of blood vessels; a skin disease characterized by peeling of the skin all over the body; cutaneous lupus erythematosus, which is identified by a rash that can appear on the face, neck, and scalp; allergic reactions; weakness and muscle spasms; alteration of heart rhythm; reduction of blood pressure after a change in body position; swelling of the salivary glands; high blood sugar levels; sugar in the urine; increases in some types of blood fats; high levels of uric acid in the blood, which can cause gout.
Very Rare Adverse Effects(may affect up to 1 in 10,000 people):
Unknown Frequency(cannot be estimated from available data): skin and lip cancer (non-melanoma skin cancer); decreased vision or eye pain due to increased pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma].
It is known that the adverse effects associated with hydrochlorothiazide can increase with higher doses of hydrochlorothiazide.
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use Irbesartan/Hydrochlorothiazide Pensa after the expiration date shown on the packaging after "CAD". The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines at the SIGRE point in your pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Irbesartan/Hydrochlorothiazide Pensa
Appearance of the Product and Package Contents
Irbesartan/Hydrochlorothiazide Pensa 300 mg/12.5 mg tablets are presented in the form of oblong, biconvex, and white tablets, marked with the code "IH12" on one side, which contain 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Irbesartan/Hydrochlorothiazide Pensa 300 mg/12.5 mg tablets are presented in packages containing 28 tablets.
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Laboratorios Cinfa, S.A.
C/ Olaz-Chipi 10, Polígono Industrial Areta
31620 Huarte-Pamplona (Navarra) – Spain
Date of the Last Revision of this Prospectus:December 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of IRBESARTAN/HYDROCHLOROTHIAZIDE PENSA 300 mg/12.5 mg TABLETS in December, 2025 is around 19.29 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for IRBESARTAN/HYDROCHLOROTHIAZIDE PENSA 300 mg/12.5 mg TABLETS – subject to medical assessment and local rules.